SEC Form 4 · accession 0000950138-17-000516
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J. Romano
Officer — Exec. VP & Chief Sci. Ofcr
Period of report
Jul 1, 2017
Accepted (ET)
Jul 5, 2017 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 1, 2017 | F | 310 | $44.81 | D | 21,986 | D |
Table II — derivative securities
No Table II lines on this filing.